Related Articles
Qianliening capsule treats benign prostatic hyperplasia via suppression of the EGF/STAT3 signaling pathway
Anti-proliferative effects of qianliening capsules on prostatic hyperplasia in vitro and in vivo
Qianliening capsule inhibits benign prostatic hyperplasia angiogenesis via the HIF‑1α signaling pathway
Qianliening capsule treats benign prostatic hyperplasia via induction of prostatic cell apoptosis
Qianliening capsules influence the apoptosis of benign prostatic hyperplasia epithelial-1 cells by regulating the extracellular matrix